On Invalid Date, Incyte (NASDAQ: INCY) reported Q4 2023 earnings per share (EPS) of $0.90, up 650% year over year. Total Incyte earnings for the quarter were $201.08 million. In the same quarter last year, Incyte's earnings per share (EPS) was $0.12.
As of Q1 2024, Incyte's earnings has grown 74.51% year over year. This is 22.66 percentage points higher than the US Biotechnology industry earnings growth rate of 51.85%. Incyte's earnings in the past year totalled $597.60 million.
What is INCY's earnings date?
Incyte's earnings date is Invalid Date. Add INCY to your watchlist to be reminded of INCY's next earnings announcement.
What was INCY's revenue last quarter?
On Invalid Date, Incyte (NASDAQ: INCY) reported Q4 2023 revenue of $1.01 billion up 9.35% year over year. In the same quarter last year, Incyte's revenue was $926.70 million.
What was INCY's revenue growth in the past year?
As of Q1 2024, Incyte's revenue has grown 8.87% year over year. This is 160.43 percentage points lower than the US Biotechnology industry revenue growth rate of 169.3%. Incyte's revenue in the past year totalled $3.70 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.